Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Optom Vis Sci. 2022 Apr 12;99(6):505–512. doi: 10.1097/OPX.0000000000001902

Table 5.

Diagnoses of non-ocular adverse events during the BLINK Study, by treatment category.

+2.50 D add
n (%)
+1.50 D add
n (%)
Single Vision
n (%)
Visual symptoms, no obvious cause 1 (2.9) 0 (0.0) 0 (0.0)
Non-ocular allergy 0 (0.0) 1 (3.4) 3 (7.0)
Non-ocular trauma 10 (28.6) 12 (41.4) 21 (48.8)
Headaches (not vision-related) 6 (17.1) 3 (10.3) 6 (14.0)
Concussion 4 (11.4) 1 (3.5) 1 (2.3)
Systemic disease 12 (34.3) 9 (31.0) 8 (18.6)
Mental health issue 2 (5.7) 2 (6.9) 4 (9.3)
Can’t categorize 0 (0.0) 1 (3.5) 0 (0.0)

Total 35 29 43